The utility of a composite biological endpoint in HIV/STI prevention trials.
Hartwell TD, Pequegnat W, Moore JL, Parker CB, Strader LC, Green AM, Quinn TC, Wasserheit JN, Klausner JD; NIMH Collaborative HIV/STD Prevention Trial Group.
Hartwell TD, et al. Among authors: wasserheit jn.
AIDS Behav. 2013 Nov;17(9):2893-901. doi: 10.1007/s10461-013-0501-5.
AIDS Behav. 2013.
PMID: 23748863
Free PMC article.